Please join Sartorius in the upcoming seminar to learn more about the iQue3 applications. Additionally, Sartorius acquired ForteBio last year and they will be giving a brief introduction on the Octet BLI technology and cover a new iQue Kit.
Please join Leica in the upcoming seminar to learn more about the THUNDER microscope available for use at MBC BioLabs 953 and 930. Computational Clearing – available exclusively on Leica Microsystems THUNDER Imagers – offers groundbreaking ease of use, throughput, speed and sensitivity for 3D tissue, live cell and model organism imaging.
BigHat Biosciences Raises $19 Million in Series A Funding
BigHat Biosciences, a novel protein therapeutics company and developer of an AI-guided antibody design platform, announced it has raised $19 million in an oversubscribed Series A funding round. BigHat is a resident company at MBC BioLabs San Carlos @ 733 Industrial Rd. Read full press release.
Cypre Announces Strategic Partnership with Charles River, Expanding 3D In Vitro Services for Cancer Immunotherapy and Targeted Therapy Drug Screening
Cypre, Inc., a resident company at MBC BioLabs San Francisco that is using 3D hydrogel technology to advance the understanding of the tumor microenvironment and predict therapeutic efficacy, announced that it has entered into a strategic partnership with Charles River Laboratories International. The partnership will provide Charles River clients with access to Cypre’s proprietary 3D tumor model platform, Falcon-X™, which will expand Charles River’s 3D in vitro testing services to further optimize immuno-oncological approaches for its clients. Read Full Press Release.
CAGE Bio Inc., an innovative biotechnology company focused on developing innovative therapies for infection, inflammation and immunology, announced the closing of a $7.2 million over-subscribed Series A financing. CAGE Bio is a resident company at MBC BioLabs San Carlos @ 733 Industrial Rd. Read full press release.